| 000 | 01668 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514181156.0 | ||
| 264 | 0 | _c20040423 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.3.979-984.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrundage, Richard C | |
| 245 | 0 | 0 |
_aIntrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMar 2004 |
||
| 300 |
_a979-84 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxazines _xadverse effects |
| 650 | 0 | 4 |
_aRNA, Viral _xbiosynthesis |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aYong, Florence H | |
| 700 | 1 | _aFenton, Terence | |
| 700 | 1 | _aSpector, Stephen A | |
| 700 | 1 | _aStarr, Stuart E | |
| 700 | 1 | _aFletcher, Courtney V | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 3 _gp. 979-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.3.979-984.2004 _zAvailable from publisher's website |
| 999 |
_c14704076 _d14704076 |
||